chlordiazepoxide hydrochloride and clidinium bromide

Generic: chlordiazepoxide hydrochloride and clidinium bromide

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name chlordiazepoxide hydrochloride and clidinium bromide
Generic Name chlordiazepoxide hydrochloride and clidinium bromide
Labeler chartwell rx, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

chlordiazepoxide hydrochloride 5 mg/1, clidinium bromide 2.5 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-696
Product ID 62135-696_459b81bd-0d79-ace2-e063-6294a90a3482
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213530
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2020-10-20

Pharmacologic Class

Classes
anticholinergic [epc] benzodiazepine [epc] benzodiazepines [cs] cholinergic antagonists [moa] decreased parasympathetic acetylcholine activity [pe] digestive/gi system activity alteration [pe] gi motility alteration [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135696
Hyphenated Format 62135-696

Supplemental Identifiers

RxCUI
889614
UPC
0362135696122
UNII
MFM6K1XWDK 91ZQW5JF1Z

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name chlordiazepoxide hydrochloride and clidinium bromide (source: ndc)
Generic Name chlordiazepoxide hydrochloride and clidinium bromide (source: ndc)
Application Number ANDA213530 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
  • 2.5 mg/1
source: ndc
Packaging
  • 120 CAPSULE in 1 BOTTLE (62135-696-12)
source: ndc

Packages (1)

62135-696-12 120 CAPSULE in 1 BOTTLE (62135-696-12)

Ingredients (2)

chlordiazepoxide hydrochloride (5 mg/1) clidinium bromide (2.5 mg/1)

Linked Drug Pages (1)

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "459b81bd-0d79-ace2-e063-6294a90a3482", "openfda": {"upc": ["0362135696122"], "unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["a0d735c2-e7a9-4843-a78d-203c9598682d"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 CAPSULE in 1 BOTTLE (62135-696-12)", "package_ndc": "62135-696-12", "marketing_start_date": "20220608"}], "brand_name": "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE", "product_id": "62135-696_459b81bd-0d79-ace2-e063-6294a90a3482", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "62135-696", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA213530", "marketing_category": "ANDA", "marketing_start_date": "20201020", "listing_expiration_date": "20261231"}